(S)-1-(4-Isopropylphenyl)ethanamine hydrochloride
97%
- Product Code: 37918
CAS:
222737-88-4
| Molecular Weight: | 199.7203 g./mol | Molecular Formula: | C₁₁H₁₈ClN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16295045 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of chiral drugs, particularly those targeting neurological and cardiovascular disorders. Its enantiomeric purity is essential for ensuring the efficacy and safety of the final drug product. Additionally, it is employed in research settings for studying receptor interactions and developing new therapeutic agents with improved selectivity and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $150.63 |
+
-
|
(S)-1-(4-Isopropylphenyl)ethanamine hydrochloride
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of chiral drugs, particularly those targeting neurological and cardiovascular disorders. Its enantiomeric purity is essential for ensuring the efficacy and safety of the final drug product. Additionally, it is employed in research settings for studying receptor interactions and developing new therapeutic agents with improved selectivity and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :